Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Homo sapiens

ABSTRACT: A Large-Scale RNAi-Based Mouse Tumorigenesis Screen Identifies New Lung Cancer Tumor Suppressors that Repress FGFR Signaling

PROVIDER: PRJNA203548 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR862905_1.fastq.gz	Fastqsanger.gz
	SRR862905_2.fastq.gz	Fastqsanger.gz
	SRR862906_1.fastq.gz	Fastqsanger.gz
	SRR862906_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

An RNAi Screen of Chromatin Proteins Identifies Tip60-p400 as a Regulator of Embryonic Stem Cell Identity

Project description:This SuperSeries is composed of the following subset Series: GSE11240: An RNAi Screen of Chromatin Proteins Identifies Tip60-p400 as a Regulator of Embryonic Stem Cell Identity, Experiment A GSE11241: An RNAi Screen of Chromatin Proteins Identifies Tip60-p400 as a Regulator of Embryonic Stem Cell Identity, Experiment B Keywords: SuperSeries Refer to individual Series

2008-07-11 | E-GEOD-11243 | biostudies-arrayexpress

Soil samples

Project description:New Caledonia Large scale analysis

| PRJNA1147865 | ENA

Transcriptional profiling of Schistosoma mansoni male parasites after culturing with female parasites for 72 hours

Project description:Retrospective analysis of RNAi hits derived from Wang et. al. has found that genes with greater transcripts-per-million (TPM) in S. mansoni are more likely to produce physical phenotypes. To create the best rate-of-return in our large-scale RNAi screen to identify essential schistosome genes that produce physical phenotypes, we quantified TPM of each gene expressed in male parasites after culturing them with female parasites for 72 hours.

2025-03-10 | GSE290988 | GEO

Large-scale Chemical Screen Identifies a Geroprotective Role of Gallic Acid in Premature Aging

Project description:Large-scale Chemical Screen Identifies a Geroprotective Role of Gallic Acid in Premature Aging

| PRJNA752087 | ENA

Large-scale RNAi screening uncovers new therapeutic targets in the human parasite Schistosoma mansoni

Project description:Large-scale RNAi screening uncovers new therapeutic targets in the human parasite Schistosoma mansoni

| PRJNA611761 | ENA

Large scale functional screen identifies genetic variants with splicing effects in modern and archaic humans

Project description:Large scale functional screen identifies genetic variants with splicing effects in modern and archaic humans

| PRJNA833320 | ENA

Project description:An in vivo genome-wide CRISPR-Cas9 screen identifies tumor suppressors

| PRJNA1156388 | ENA

RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug.

Project description:Acute myeloid leukemia (AML) is characterized by a marked genetic heterogeneity, which complicates the development of novel therapeutics. The delineation of pathways essential within the patient-individual mutational background might overcome this limitation and facilitate personalized treatment. We report the results of a large-scale lentiviral loss-offunction RNA-interference-(RNAi)-screen in primary leukemic cells. Stringent validation identified six genes (BNIPL1, ROCK1, RPS13, STK3, SNX27, WDHD1) whose knockdown impaired growth and viability of the cells. Dependence on these genes was not caused by mutation or overexpression and while some of the candidates seemed to be rather patientspecific, others were essential in cells isolated from other AML patients. In addition to the phenotype observed after ROCK1 knockdown, treatment with the approved ROCK-inhibitor fasudil resulted in increased apoptosis and decreased viability of primary AML cells. In contrast to observations in some other malignancies, ROCK1-inhibition did not foster growth of immature malignant progenitors; but was also toxic to this cell fraction in feeder-co-culture and xenotransplantion experiments, indicating a distinct effect of ROCK1 inhibition on leukemic progenitors. We conclude that large scale RNAi screens in primary patient-derived cells are feasible and can complement other methods for personalized cancer therapies, such as expression and mutation profiling. Large-scale lentiviral loss-of-function shRNA screen in primary leukemic cells with two time points, exome sequencing of primary leukemic cells, and a gene expression profiling of primary cells from four leukemic and three healthy samples.

2015-05-16 | E-GEOD-68925 | biostudies-arrayexpress

Identification of miRNA target genes in C. elegans by RIP-chip-SRM

Project description:RIP-chip-SRM : a New Combinatorial Large Scale Approach Identifies a Set of Translationally Regulated bantam/miR 58 Targets in C. elegans RNA binding protein immunopurification + microarray + targeted protein quantification via Selected Reaction Monitoring This SuperSeries is composed of the SubSeries listed below.

2012-03-01 | GSE32944 | GEO

A functional taxonomy of tumor suppression in oncogenic KRAS-driven lung cancer

Project description:Extensive cancer genotyping has identified a large number of putative tumor suppressor genes. However, genome sequencing data alone is insufficient to uncover the importance or the specific functional roles of these genes during carcinogenesis. It is generally unclear whether more frequently mutated tumor suppressors are also more consequential for tumor development. Furthermore, whether tumor suppressors restrict the rate of tumor growth, decrease the probability of incipient tumorigenesis, or limit the emergence of particularly fast-growing clones remains unknown for even the most well-studied tumor suppressors. Here we use a multiplexed autochthonous mouse model of oncogenic Kras-driven human lung adenocarcinoma to quantify the impact of forty-eight known and putative tumor suppressor genes on diverse aspects of carcinogenesis at an unprecedented scale and resolution. We discover many previously understudied functional tumor suppressors that constrain multiple aspects of carcinogenesis in vivo. Inactivation of some genes substantially elevates tumor growth rate, while the inactivation of others increases the probability of tumor initiation and/or the emergence of exceptionally large tumors. While some known and novel functional tumor suppressor genes exert particularly strong effects during specific phases of tumorigenesis, others impact multiple facets of tumor development. These direct and causal analyses uncover an unexpectedly complex functional landscape of tumor suppression. This map of carcinogenesis has implications for understanding cancer evolution, interpreting clinical cancer genome sequencing data, and directing approaches to limit tumor initiation and progression.

2021-02-04 | GSE146302 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data